{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:01:14Z","timestamp":1785434474132,"version":"3.56.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Shortly before his death in 1995, Kenneth B. Schwartz, a cancer patient at Massachusetts General Hospital (MGH), founded the Kenneth B. Schwartz Center. The Schwartz Center is a non-profit organization dedicated to supporting and advancing compassionate health care delivery, which provides hope to the patient, support to caregivers, and sustenance to the healing process. The center sponsors the Schwartz Center Rounds, a monthly multidisciplinary forum where caregivers reflect on important psychosocial issues faced by patients, their families, and their caregivers, and gain insight and support from fellow staff members.<\/jats:p>\n               <jats:p>Interest in complementary and alternative medicine (CAM) has grown exponentially in the past decade, fueled by Internet marketing, dissatisfaction with mainstream medicine, and a desire for patients to be actively involved in their health care. There is a large discordance between physician estimates and reported prevalence of CAM use. Many patients do not disclose their practices mainly because they believe CAM falls outside the rubric of conventional medicine or because physicians do not ask. Concern about drug interactions and adverse effects are compounded by a lack of Food and Drug Administration regulation. Physicians need to be informed about CAM and be attuned to the psychosocial needs of patients.<\/jats:p>","DOI":"10.1634\/theoncologist.6-5-463","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T21:38:39Z","timestamp":1093383519000},"page":"463-473","source":"Crossref","is-referenced-by-count":22,"title":["Complementary, Alternative, Integrative, or Unconventional Medicine?"],"prefix":"10.1093","volume":"6","author":[{"given":"Richard T.","family":"Penson","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar M.","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Seiden","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Chabner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas J.","family":"Lynch","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,10,1]]},"reference":[{"key":"2021122211275885300_R1","first-page":"2","article-title":"Incorporating new (mind\/body, alternative, complementary, or integrative) medicine into everyday care","volume":"13","year":"2001","journal-title":"Qual Lett Healthc Lead"},{"key":"2021122211275885300_R2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.319.7211.693","article-title":"What is complementary medicine?","volume":"319","author":"Zollman","year":"1999","journal-title":"BMJ"},{"key":"2021122211275885300_R3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/acm.2000.6.415","article-title":"Use of complementary medicine by adult patients participating in HIV\/AIDS clinical trials","volume":"6","author":"Sparber","year":"2000","journal-title":"J Altern Complement Med"},{"key":"2021122211275885300_R4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O","article-title":"The prevalence of complementary\/alternative medicine in cancer","volume":"83","author":"Ernst","year":"1998","journal-title":"Cancer"},{"key":"2021122211275885300_R5","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2000.18.13.2505","article-title":"Complementary\/alternative medicine in a comprehensive cancer center and the implications for oncology","volume":"18","author":"Richardson","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122211275885300_R6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199301283280406","article-title":"Unconventional medicine in the United States\u2014prevalence, costs, and patterns of use","volume":"328","author":"Eisenberg","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"2021122211275885300_R8","first-page":"3001a","article-title":"Utilization of the Internet by oncology patients to obtain cancer related information","volume":"20","author":"Metz","year":"2001","journal-title":"Ann Am Soc Clin Oncol"},{"key":"2021122211275885300_R9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s005209900111","article-title":"Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine\/oncology and haematology","volume":"8","author":"Kappauf","year":"2000","journal-title":"Support Care Cancer"},{"key":"2021122211275885300_R10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9610(00)00358-5","article-title":"A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites","volume":"179","author":"Morris","year":"2000","journal-title":"Am J Surg"},{"key":"2021122211275885300_R11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jnci\/92.1.42","article-title":"Alternative therapies used by women with breast cancer in four ethnic populations","volume":"92","author":"Lee","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2021122211275885300_R12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/acm.2000.6.531","article-title":"Ethnic differences in complementary and alternative medicine use among cancer patients","volume":"6","author":"Maskarinec","year":"2000","journal-title":"J Altern Complement Med"},{"key":"2021122211275885300_R13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3322\/canjclin.49.6.362","article-title":"Evaluating complementary and alternative therapies for cancer patients","volume":"49","author":"Cassileth","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"2021122211275885300_R14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.282.7.651","article-title":"Association between use of unconventional therapies and conventional medical services","volume":"282","author":"Druss","year":"1999","journal-title":"JAMA"},{"key":"2021122211275885300_R15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bmj.322.7279.119","article-title":"Integrated medicine","volume":"322","author":"Rees","year":"2001","journal-title":"BMJ"},{"key":"2021122211275885300_R16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2000.18.3.668","article-title":"Research on complementary\/alternative medicine for patients with breast cancer: a review of the biomedical literature","volume":"18","author":"Jacobson","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122211275885300_R17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bmj.322.7279.161","article-title":"Research into complementary and alternative medicine: problems and potential","volume":"322","author":"Nahin","year":"2001","journal-title":"BMJ"},{"key":"2021122211275885300_R18","first-page":"38","article-title":"Research of complementary\/alternative medicine therapies in oncology: promising but challenging","volume":"17","author":"Richardson","year":"1999","journal-title":"J Clin Oncol"},{"key":"2021122211275885300_R19","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/bmj.319.7223.1486","article-title":"Complementary medicine and the patient","volume":"319","author":"Zollman","year":"1999","journal-title":"BMJ"},{"key":"2021122211275885300_R20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0885-3924(00)00190-1","article-title":"Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review","volume":"20","author":"Pan","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"2021122211275885300_R21","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0959-8049(99)00199-9","article-title":"Testing complementary and alternative therapies within a research protocol","volume":"35","author":"Walker","year":"1999","journal-title":"Eur J Cancer"},{"key":"2021122211275885300_R22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/acm.2000.6.493","article-title":"Integrity and research: introducing the concept of dual blindness. How blind are double-blind clinical trials in alternative medicine?","volume":"6","author":"Caspi","year":"2000","journal-title":"J Altern Complement Med"},{"key":"2021122211275885300_R23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.279.13.1005","article-title":"A close look at therapeutic touch","volume":"279","author":"Rosa","year":"1998","journal-title":"JAMA"},{"key":"2021122211275885300_R24","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jnci\/92.19.1558","article-title":"Alternative therapies getting notice through Best Case Series Program","volume":"92","author":"Vanchieri","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2021122211275885300_R25","first-page":"49","article-title":"Factors that shape alternative medicine: the role of the alternative medicine research community","volume":"6","author":"Eskinazi","year":"2000","journal-title":"Altern Ther Health Med"},{"key":"2021122211275885300_R26","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/archinte.159.19.2273","article-title":"A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit","volume":"159","author":"Harris","year":"1999","journal-title":"Arch Intern Med"},{"key":"2021122211275885300_R27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(97)02293-9","article-title":"Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials","volume":"350","author":"Linde","year":"1997","journal-title":"Lancet"},{"key":"2021122211275885300_R28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.313.7052.253","article-title":"St John's wort for depression\u2014an overview and meta-analysis of randomised clinical trials","volume":"313","author":"Linde","year":"1996","journal-title":"BMJ"},{"key":"2021122211275885300_R29","first-page":"57","article-title":"Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested with a cohort study","volume":"7","author":"Grossarth-Maticek","year":"2001","journal-title":"Altern Ther Health Med"},{"key":"2021122211275885300_R30","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM199811053391909","article-title":"Arsenic\u2014new life for an old potion","volume":"339","author":"Gallagher","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM200103013440911","article-title":"Green tea and gastric cancer","volume":"344","author":"Sano","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R32","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/bmj.319.7216.1050","article-title":"Herbal medicine","volume":"319","author":"Vickers","year":"1999","journal-title":"BMJ"},{"key":"2021122211275885300_R33","first-page":"1491","article-title":"Patient dies of alternative cancer remedy","volume":"321","author":"Gottlieb","year":"2000","journal-title":"BMJ"},{"key":"2021122211275885300_R34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/gyno.2000.5743","article-title":"Alternative medicine in gynecologic oncology: A case report","volume":"77","author":"Gruenigen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122211275885300_R35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1753-4887.2000.tb07810.x","article-title":"Beta carotene: from biochemistry to clinical trials","volume":"58","author":"Pryor","year":"2000","journal-title":"Nutr Rev"},{"key":"2021122211275885300_R36","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","article-title":"St. John's Wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4","volume":"68","author":"Durr","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"2021122211275885300_R38","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1056\/NEJM200006083422309","article-title":"Cancer and herbs","volume":"342","author":"Kessler","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199809103391109","article-title":"Appetite suppressants and valvular heart disease","volume":"339","author":"Devereux","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jama.286.2.208","article-title":"Herbal medicines and perioperative care","volume":"286","author":"Ang-Lee","year":"2001","journal-title":"JAMA"},{"key":"2021122211275885300_R41","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1200\/JCO.2000.18.13.2501","article-title":"Discussing complementary therapies with cancer patients: what should we be talking about?","volume":"18","author":"Burstein","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122211275885300_R42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1592\/phco.20.17.1289.34898","article-title":"The psychosocial aspects of complementary and alternative medicine","volume":"20","author":"Cauffield","year":"2000","journal-title":"Pharmacotherapy"},{"key":"2021122211275885300_R43","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJM199906033402211","article-title":"Use of alternative medicine\u2013a marker for distress?","volume":"340","author":"Holland","year":"1999","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R44","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199906033402206","article-title":"Use of alternative medicine by women with early-stage breast cancer","volume":"340","author":"Burstein","year":"1999","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R45","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2001.19.9.2439","article-title":"Determinants of the use of complementary therapies by patients with cancer","volume":"19","author":"Paltiel","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122211275885300_R46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0952-8180(00)00195-1","article-title":"Herbal medicines: current trends in anesthesiology practice\u2013a hospital survey","volume":"12","author":"Kaye","year":"2000","journal-title":"J Clin Anesth"},{"key":"2021122211275885300_R47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<615::AID-CNCR18>3.0.CO;2-P","article-title":"Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy","volume":"88","author":"Kao","year":"2000","journal-title":"Cancer"},{"key":"2021122211275885300_R48","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/bmj.319.7224.1558","article-title":"Complementary medicine and the doctor","volume":"319","author":"Zollman","year":"1999","journal-title":"BMJ"},{"key":"2021122211275885300_R49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJM199809173391210","article-title":"Alternative medicine\u2014the risks of untested and unregulated remedies","volume":"339","author":"Angell","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122211275885300_R50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-1-1","article-title":"Message to complementary and alternative medicine: evidence is a better friend than power","volume":"1","author":"Vickers","year":"2001","journal-title":"BMC Complement Altern Med"},{"key":"2021122211275885300_R51","first-page":"623","article-title":"Use of complementary medicine by adult patients participating in cancer clinical trials","volume":"27","author":"Sparber","year":"2000","journal-title":"Oncol Nurs Forum"},{"key":"2021122211275885300_R52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/1097-0142(20000815)89:4<873::AID-CNCR21>3.0.CO;2-K","article-title":"Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey","volume":"89","author":"Sollner","year":"2000","journal-title":"Cancer"},{"key":"2021122211275885300_R53","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/1099-1611(200009\/10)9:5<428::AID-PON481>3.0.CO;2-L","article-title":"Resource use in women completing treatment for breast cancer","volume":"9","author":"Edgar","year":"2000","journal-title":"Psychooncology"},{"key":"2021122211275885300_R54","first-page":"821","article-title":"What can general practice learn from complementary medicine?","volume":"50","author":"White","year":"2000","journal-title":"Br J Gen Pract"},{"key":"2021122211275885300_R55","first-page":"2468","article-title":"Assessment of health locus of control in the use of nonconventional remedies by patients with rheumatic diseases","volume":"26","author":"Ramos-Remus","year":"1999","journal-title":"J Rheumatol"},{"key":"2021122211275885300_R56","first-page":"1345","article-title":"Cancer, unproven therapies, and magic","volume":"14","author":"Wein","year":"2000","journal-title":"Oncology"},{"key":"2021122211275885300_R57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/acm.2000.6.445","article-title":"Patient risk-taking attitude and the use of complementary and alternative medical services","volume":"6","author":"Sturm","year":"2000","journal-title":"J Altern Complement Med"},{"key":"2021122211275885300_R58","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJM199411033311823","article-title":"Choice in healing: integrating the best of conventional and complementary approaches to cancer","volume":"331","author":"Fitzgerald","year":"1994","journal-title":"N Engl J Med"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.6-5-463","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.6-5-463","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/6\/5\/463\/41837564\/oncolo_6_5_463.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/6\/5\/463\/41837564\/oncolo_6_5_463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:28:00Z","timestamp":1640197680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/6\/5\/463\/6387716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,10,1]]},"published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.6-5-463","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,10,1]]},"published":{"date-parts":[[2001,10,1]]}}}